Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > T-Vec

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Mar 06, 2023 11:56am

99 Views

Post# 35321473

RE:RE:RE:T-Vec

the pumpers have been over zealous on this stock for quite some time. I told youins to take a more realistic approach with your expectations. I think this stock has good prospects of going up at some point in the future but I dont expect the moon her.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments